Testing effectiveness (Phase 2)Ended earlyNCT00480935What this trial is testingNeoadjuvant Sutent for Patients With Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma University Health Network, Toronto 3
Not applicableUnknownNCT01141816What this trial is testingContrast-enhanced Ultrasound for Follow-up After Radiofrequency Ablation of Kidney LesionsWho this might be right forCarcinoma, Renal Cell St. Joseph's Healthcare Hamilton 30
Very early researchEnded earlyNCT02885649What this trial is testingEnzalutamide Before Surgery in Treating Patients With Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaStage I Renal Cell Cancer Rutgers, The State University of New Jersey 3
Early research (Phase 1)Ended earlyNCT05121948What this trial is testingHC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Who this might be right forSquamous Cell Carcinoma of Head and NeckColo-rectal CancerNon Small Cell Lung Cancer+3 more HiberCell, Inc. 35
Early research (Phase 1)Looking for participantsNCT06332755What this trial is testingStudy to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCWho this might be right forNon-small Cell Lung Cancer(NSCLC)Head and Neck Squamous Cell Carcinoma(HNSCC)Renal Cell Carcinoma(RCC)+2 more LG Chem 76
Not applicableUnknownNCT01890590What this trial is testingA Phase II Study of Cyberknife Radiosurgery for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Beth Israel Deaconess Medical Center 46
Not applicableStudy completedNCT00505310What this trial is testingBiobehavioral Effects of Emotional Expression in CancerWho this might be right forKidney Cancer M.D. Anderson Cancer Center 705
Not applicableStudy completedNCT01210482What this trial is testingTemsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)Who this might be right forRenal Cell Carcinoma Pfizer 1,050
Large-scale testing (Phase 3)Study completedNCT02853331What this trial is testingStudy to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 861
Early research (Phase 1)Ended earlyNCT06052852What this trial is testingStudy of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesWho this might be right forTriple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more Bolt Biotherapeutics, Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT03311334What this trial is testingDSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more Sumitomo Pharma America, Inc. 47
Early research (Phase 1)Active Not RecruitingNCT05581004What this trial is testingEvaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid TumorsNSCLCHNSCC+9 more Genentech, Inc. 165
Large-scale testing (Phase 3)UnknownNCT01099423What this trial is testingImmediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC 99
Early research (Phase 1)UnknownNCT05259319What this trial is testingStudy Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)Who this might be right forMetastatic Non Small Cell Lung CancerMetastatic Bladder CancerMetastatic Renal Cell Carcinoma+1 more Centre Georges Francois Leclerc 92
Not applicableLooking for participantsNCT06088134What this trial is testingContrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)Who this might be right forClear Cell Renal Cell CarcinomaPrognostic Cancer ModelRecurrent Renal Cell Cancer Mingzhao Xiao 800
Not applicableUnknownNCT02849119What this trial is testingTransperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial NephrectomyWho this might be right forRenal Cell Carcinoma Samsung Medical Center 106
Testing effectiveness (Phase 2)Looking for participantsNCT04981509What this trial is testingTesting of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerWho this might be right forHereditary Leiomyomatosis and Renal Cell CarcinomaPapillary Renal Cell CarcinomaRenal Cell Carcinoma+3 more National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Ended earlyNCT03562507What this trial is testingMulti-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma, Metastatic University of Michigan Rogel Cancer Center 8
Not applicableWithdrawnNCT04680416What this trial is testingTissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint InhibitorsWho this might be right forRenal Clear Cell Carcinoma TScan Therapeutics, Inc.
Not applicableWithdrawnNCT04609800What this trial is testingStudy on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.Who this might be right forRenal Cell Carcinoma Ipsen